The DOI matches its Crossref record.
Nerve Growth Factor Is a Potential Therapeutic Target in Breast Cancer
Abstract
We show here that nerve growth factor (NGF), the prototypic neurotrophin, can be targeted in breast cancer to inhibit tumor cell proliferation, survival, and metastasis. Analysis of a series of biopsies revealed widespread expression of NGF in the majority of human breast tumors, with anti-NGF immunoreactivity concentrated in the epithelial cancer cells. Moreover, immunodeficient mice xenografted with human breast cancer cells and treated with either anti-NGF antibodies or small interfering RNA against NGF displayed inhibited tumor growth and metastasis. Such treatments directed against NGF induced a decrease in cell proliferation with a concomitant increase in apoptosis of breast cancer cells and an inhibition of tumor angiogenesis. Together, these data indicate that targeting NGF in breast cancer may have therapeutic ramifications. [Cancer Res 2008;68(2):346–51]
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Perineural invasion in cancer: A Review of the Literature
Liebig, C., Ayala, G., Wilks, J. A., Berger, D. H., & Albo, D. (2009) · Cancer · doi:10.1002/cncr.24396 · Cited by 1,237
Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis
Mapp, P. I., & Walsh, D. A. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.80 · Cited by 638
Cancer‐associated fibroblasts in breast cancer: Challenges and opportunities
Hu, D., Li, Z., Zheng, B., Lin, X., Pan, Y., Gong, P., Zhuo, W., Hu, Y., Chen, C., Chen, L., et al. (2022) · Cancer Communications · doi:10.1002/cac2.12291 · Cited by 286
Nerve–Cancer Cell Cross-talk: A Novel Promoter of Tumor Progression
Jobling, P., Pundavela, J., Oliveira, S. M. R., Roselli, S., Walker, M. M., & Hondermarck, H. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3180 · Cited by 272
Self-citationmiR-139-5p is a regulator of metastatic pathways in breast cancer
Krishnan, K., Steptoe, A. L., Martin, H. C., Pattabiraman, D. R., Nones, K., Waddell, N., Mariasegaram, M., Simpson, P. T., Lakhani, S. R., Vlassov, A., et al. (2013) · RNA · doi:10.1261/rna.042143.113 · Cited by 134
Metadata
- Authors
- Adriaenssens, E., Vanhecke, E., Saule, P., Mougel, A., Page, A., Romon, R., Nurcombe, V., Le Bourhis, X., & Hondermarck, H.
- Venue
- Cancer Research
- Published
- 2008-01-15
- Volume
- 68
- Issue
- 2
- Pages
- 346-351
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2015670731
- Cited by
- 190
- References
- 0
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nerve Growth Factor Is a Potential Therapeutic Target in Breast Cancer. https://app.cochat.ai/papers/10.1158/0008-5472.can-07-1183
- The paper
- Adriaenssens, E., Vanhecke, E., Saule, P., Mougel, A., Page, A., Romon, R., Nurcombe, V., Le Bourhis, X., & Hondermarck, H. (2008). Nerve Growth Factor Is a Potential Therapeutic Target in Breast Cancer. Cancer Research. https://doi.org/10.1158/0008-5472.can-07-1183
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.